Literature DB >> 10675798

Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats.

J X Hao1, X J Xu, L Urban, Z Wiesenfeld-Hallin.   

Abstract

The effect of systemic gabapentin, a novel antiepileptic and analgesic, was tested on allodynia-like behaviors in spinal cord injured rats. On the first day of treatment 30 mg/kg intraperitoneal gabapentin did not alleviate hyper-reactivity to mechanical and cold stimulation. The allodynia was significantly reduced by 100 mg/kg gabapentin, which however, produced sedation and motor impairments. Repeated administration of 30 mg/kg gabapentin once a day produced a gradually increasing anti-allodynic effect. Total alleviation of mechanical allodynia was observed in most rats after the third administration of gabapentin. Thus, build-up of the antiallodynic effect of gabapentin may develop through a time dependent mechanism or alternatively through a gradual accumulation of the effective central nervous system concentration of the drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675798     DOI: 10.1016/s0304-3940(00)00787-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Validity of acute and chronic tactile sensory testing after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Leslie M Clark; Karen J Hutchinson; Anne D Kloos; Lesley C Fisher; D Michele Basso
Journal:  Exp Neurol       Date:  2010-07-17       Impact factor: 5.330

2.  A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Authors:  T G Tzellos; G Papazisis; K A Toulis; Ch Sardeli; D Kouvelas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 3.  Pharmacologic treatment of neuropathic pain.

Authors:  M S Wallace
Journal:  Curr Pain Headache Rep       Date:  2001-04

4.  Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.

Authors:  W Xiao; A Boroujerdi; G J Bennett; Z D Luo
Journal:  Neuroscience       Date:  2006-11-02       Impact factor: 3.590

5.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

Review 6.  Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.

Authors:  Thrasivoulos G Tzellos; Georgios Papazisis; Ekaterini Amaniti; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953

7.  The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.

Authors:  Molly S Crowe; Catheryn D Wilson; Emma Leishman; Paul L Prather; Heather B Bradshaw; Matthew L Banks; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2017-11-20       Impact factor: 8.739

8.  Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pain Res Treat       Date:  2012-03-18

9.  Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric T Hama; James P Pearson; Jacqueline Sagen
Journal:  Pharmacol Res Perspect       Date:  2014-03-13

Review 10.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.